PS(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

KQUCBTRVYDUHMT-RKFXOYQJSA-N

InChI Key

KQUCBTRVYDUHMT-RKFXOYQJSA-N

IUPAC name

(2S)-2-amino-3-[[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-nonadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

Preferred name

PS(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:184241

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon

Observed in differential profiles

• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_vs_Exercise
• G1_PBS_vs_G2_DSS
• Control_12h_vs_Toxocara canis_12h
• Control_12h_vs_Toxocara canis_12h
• Male_19_days_vs_Male_1_day